Scholars Central

Conference abstractPublished 16 Apr 2018

Azilsartan induces oxidative stress and NF-kB medicated apoptosis in hepatocellular carcinoma cell line HepG2

Authors: Elham Ahmadian, Aziz Eftekhari, Mohammad Ali Eghbal

Tabriz University of Medical Sciences, Iran

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Over expression of renin angiotensin system (RAS) and nuclear factor-kappaB (NF-kB) has a key role in various cancers. Blockade of RAS and NF-kB pathway has been suggested to reduce cancer cell proliferation. This study aimed to investigate the role of angiotensin II and NF-kB pathway in liver hepatocellular carcinoma cell line (HepG2) proliferation by using azilsartan (as a novel Ag II antagonist) and Bay11-7082 (as NF-kB inhibitor). HepG2 cells were treated with different concentrations of Azilsartan and Bay11-7082. Cytotoxicity was determined after 24, 48 and 72 hours by MTT assay. Reactive Oxygen Spices (ROS) generation and cytochrome C release were measured following Azilsartan and Bay11-7082 treatment. Apoptosis was analyzed qualitatively by DAPI staining and quantitatively through flow cytometry methodologies and Bax and Bcl-2 mRNA and protein levels were assessed by real time PCR and ELISA methods, respectively. The cytotoxic effects of different concentration of Azilsartan and Bay11-7082 on HepG2 cells were observed as a reduction in cell viability, ROS formation, cytochrome C release and apoptosis induction. These effects were found to correlate with a shift in Bax level and a downward trend in the expression of Bcl-2. These findings suggest that Azilsartan and Bay11-7082 in combination or alone have strong potential for development as an agent for prevention against liver cancer. Recent Publications 1. Ahmadian E, Eftekhari A, Babaei H, M Nayebi A and A Eghbal M (2017) Anti-cancer effects of citalopram on hepatocellular carcinoma cells occur via cytochrome c release and the activation of NF-kB. Anticancer Agents Medicinal Chemistry; 17(11): 1570-1577. 2. Ahmadian E, Eftekhari A, Fard J K, Babaei H, Nayebi A M, Mohammadnejad D and Eghbal M A (2017) In vitro and in vivo evaluation of the mechanisms of Citalopram-induced hepatotoxicity. Archives of Pharmacal Research; 40(11): 1296-313.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Drug Designing: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalDrug Designing: Open Access
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Elham Ahmadian”
  • BylineArticles whose byline prints “Aziz Eftekhari”
  • BylineArticles whose byline prints “Mohammad Ali Eghbal”